EGFR and non-small cell lung carcinoma: (6) proposed a graded prognostic assessment model for NSCLC patients with BOM that relied on smoking, EGFR sensitive/ALK mutations status, loss of weight, hypoalbuminemia, and primary site treated by surgery or radiotherapy.